Prognostic and predictive factors of early breast cancer

Chen, Zhongjie; Yan, Mei; Zhuang, Hongqing; Hao, Jianlei; Li, Ruiying; Wang, Ping

doi:10.1007/s11805-010-0526-8

Cited by 2 publications

(3 citation statements)

References 20 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The selection of studies was conducted to identify 11 studies related to prognostic factors of recurrence in patients with operable breast cancer in Asia with total sample of 5,213 patients [ 7 ], [ 10 ], [ 11 ], [ 12 ], [ 13 ], [ 14 ], [ 15 ], [ 16 ], [ 17 ], [ 18 ], [ 19 ] ( Table 1 ).…”

Section: Resultsmentioning

confidence: 99%

“…Another study in Japan found that HER2 status and axillary metastases are independent predictors of recurrence in breast cancer patients [ 12 ]. In China population, it has been reported that axillary lymph nodal status is the only risk factor of significant impact on 10-year [ 13 ]. In Thailand population, ER + /PR + and HER2 − patients have a higher risk of recurrence in later than 5 years, especially in patients with high ER titer and low nuclear grade.…”

Section: Discussionmentioning

confidence: 99%

See 1 more Smart Citation

Prognostic Factors of Local-Regional Recurrence in Patients with Operable Breast Cancer in Asia: A Meta-Analysis

Harahap¹,

Nindrea²

2019

Open Access Maced J Med Sci

View full text Add to dashboard Cite

BACKGROUND: Cause of recurrence of breast cancer is multifactorial. Also, the occurrence of breast cancer in Asian patients has some different factors from the recurrence of breast cancer in western countries. AIM: This study aims to determine the prognostic factors of local-regional recurrence in patients with operable breast cancer in Asia. METHODS: The authors conducted a meta-analysis of published research articles published in an online database of PubMed, ProQuest and EBSCO between January 2000 and July 2018. Pooled risk ratios (RR) were calculated using fixed and random-effect models. Data were processed by using Review Manager 5.3 (RevMan 5.3). RESULTS: This study reviewed 879 articles. There were 11 studies conducted a systematic review then continued by meta-analysis of relevant data with total patients involved were 5,213 patients. The prognostic factors found of local-regional recurrence in patients with operable breast cancer were Nodal (N) stage with the highest risk ratio (RR = 6.35 [95% CI 3.78-10.67]) followed by HER2 positive (RR = 2.14 [95% CI 1.16-3.97]), stage of cancer (RR = 1.82 [95% CI 1.44-2.31]), tumor size (RR = 1.55 [95% CI 1.04-2.31]), tumor grade (RR = 1.43 [95% CI 1.23-1.65]), PR status (RR = 0.65 [95% CI 0.48-0.88]) and the least was ER status (RR = 0.60 [95% CI 0.39-0.91]). Homogeneity of variance was found in N stage, tumor size and tumor grade for recurrence of operable breast cancer. CONCLUSION: This meta-analysis confirmed the correlation of N stage, HER2, stage of cancer, tumour size, tumour grade, ER and PR status with recurrence in patients with operable breast cancer in Asia.

show abstract

Section: Resultsmentioning

confidence: 99%

Section: Discussionmentioning

confidence: 99%

Prognostic Factors of Local-Regional Recurrence in Patients with Operable Breast Cancer in Asia: A Meta-Analysis

Harahap¹,

Nindrea²

2019

Open Access Maced J Med Sci

View full text Add to dashboard Cite

show abstract

“…Worldwide, the use of the indicated markers is widely recommended to define subtypes of BC and to even rank them according to their severity . These differences between tumor subtypes are often associated with clinical features, such as relapse‐free and overall survival and also treatments.…”

Section: Introductionmentioning

confidence: 99%

Using network and functional enrichment clustering analyses to find therapeutic targets for breast cancer: The role of cyclin‐dependent kinase 2

Valenzuela

Assar

2018

Math Methods in App Sciences

View full text Add to dashboard Cite

MSC Classification: 62H30; 62F03Population aging is rapidly increasing in developing countries; thus, covering medical needs for breast cancer diagnosis and treatment is a priority in Latin America. We describe an approach for integrating differential expression analysis, biological pathway enrichment, in silico transcription-binding sites and network topology, to find key genes that may be used as biomarkers or therapeutic targets. This approach is based on publicly available data from microarrays of the MCF-7 breast cancer cell line treated with estrogen. We found significant estrogen-responsive genes, which were used as nodes to construct networks based on protein-protein interactions reported in the literature. Then, we conducted a topology analysis of the networks, revealing the most-connected nodes, ie, those responsible for maintaining the network structure corresponding to genes with well-acknowledged functions in G1/S cell cycle transition, such as cyclin-dependent kinase 2 (CDK2), which has been proposed as a therapeutic target in classical biochemical studies. In addition, analyses of biological pathway enrichment and in silico transcription-binding sites support the biological meaning and importance of these key genes and help to decide the best target genes. Therefore, we postulate that the integrative bioinformatics approach shown here, unlike the classical bioinformatics approach that only includes differentially expressed genes and enriched biological pathways, can be applied as an approach for finding novel biomarkers and/or therapeutic target genes for nonresponsive treatments. KEYWORDS breast cancer biomarkers, functional enrichment analysis, gene expression clustering, gene network analysis 8514 VALENZUELA AND ASSAR 8515to new cases, and the second-leading cancer with respect to mortality in women. According to BC data, 3 over half of the deaths occur in South America and Africa. 3 Studying BC is difficult because it is genetically, morphologically, and clinically heterogeneous. To obtain better diagnoses and treatments, many studies have tried to classify this cancer into subtypes, using morphological and molecular approaches. Gene expression analyses have identified at least 4 intrinsic subtypes of BC: Luminal A, Luminal B, HER2-enriched, and a triple-negative group with significant differences in terms of risk, response to therapies, and prognoses. 4 The histological characteristics of BC are currently used to determine subtype, size, lymph node status, and the cytoplasmic and nuclear grade.Worldwide, the use of the indicated markers is widely recommended to define subtypes of BC and to even rank them according to their severity. 5,6 These differences between tumor subtypes are often associated with clinical features, such as relapse-free and overall survival 7 and also treatments. The triple-negative subtype has the worst survival rates, and tamoxifen is used against ER+ cells. However, there is a controversy over whether ER, PR, HER2, and KI67 proteins can effectively capture the complex ...

show abstract

Prognostic and predictive factors of early breast cancer

Cited by 2 publications

References 20 publications

Prognostic Factors of Local-Regional Recurrence in Patients with Operable Breast Cancer in Asia: A Meta-Analysis

Prognostic Factors of Local-Regional Recurrence in Patients with Operable Breast Cancer in Asia: A Meta-Analysis

Using network and functional enrichment clustering analyses to find therapeutic targets for breast cancer: The role of cyclin‐dependent kinase 2

Contact Info

Product

Resources

About